3-Nitrotyrosine immunoreactivity in olfactory receptor neurons of patients with Alzheimer's disease: Implications for impaired odor sensitivity

Neurobiology of Aging

Volumn 24, Issue 5, 2003, Pages 663-673

  Getchell, M L ^a   Shah, D S ^a   Buch, S K ^a   Davis, D G ^a   Getchell, T V ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Aging; Free radicals; Olfactory threshold; Oxidative stress; Peroxynitrite

Indexed keywords

3 NITROTYROSINE; CD68 ANTIGEN; FREE RADICAL; ION CHANNEL; SCAVENGER RECEPTOR; 3-NITROTYROSINE; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; DRUG DERIVATIVE; LEUKOCYTE ANTIGEN; THIOL ESTER HYDROLASE; TYROSINE; UBIQUITIN THIOLESTERASE;

ADULT; AGE; AGED; ALZHEIMER DISEASE; AMINO ACID ANALYSIS; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE ACTIVATION; MALE; NERVE DEGENERATION; NERVE FUNCTION; NEUROPATHOLOGY; NEUROTRANSMISSION; ODOR; OLFACTORY DISCRIMINATION; OLFACTORY RECEPTOR; OXIDATIVE STRESS; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; PROTEIN MODIFICATION; SENSORY DYSFUNCTION; SMELLING DISORDER; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; CASE CONTROL STUDY; COMPARATIVE STUDY; MENTAL HEALTH; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MENTAL STATUS SCHEDULE; OLFACTION DISORDERS; OLFACTORY RECEPTOR NEURONS; SENSORY THRESHOLDS; THIOLESTER HYDROLASES; TYROSINE; UBIQUITIN THIOLESTERASE;

EID: 0042385120     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00195-1     Document Type: Article

References (88)

1. Consensus report on the working group on: molecular and biochemical markers of Alzheimer's Disease. The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and National Institute on Aging Working Group. Neurobiol Aging 1998;19:109-16.
2. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U.S.A. 90:1993;7915-7922.
3. Apter A.J., Gent J.F., Frank M.E. Fluctuating olfactory sensitivity and distorted odor perception in allergic rhinitis. Arch. Otolaryngol. Head Neck Surg. 125:1999;1005-1010.
4. Ashok B.T., Ali R. The aging paradox: free radical theory of aging. Exp. Gerontol. 34:1999;293-303.
5. Bacon A.W., Bondi M.W., Salmon D.P., Murphy C. Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction. Ann. NY Acad. Sci. 855:2002;723-731.
6. Baraniuk J.N. Mechanisms of allergic rhinitis. Curr. Allergy Asthma Rep. 1:2001;207-217.
7. Behl C. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Prog. Neurobiol. 57:1999;301-323.
8. Butterfield D.A., Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences invovling amyloid β-peptide-associated free radical oxidative stress. Free Radic. Biol. Med. 32:2002;1050-1060.
9. Carpenter A.F., Carpenter P.W., Markesbery W.R. Morphometric analysis of microglia in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 52:1993;601-608.
10. Crino P.B., Martin J.A., Hill W.D., Greenberg B., Lee V.M.Y., Trojanowski J.Q. β-Amyloid peptide and amyloid precursor proteins in olfactory mucosa of patients with Alzheimer's disease, Parkinson's disease, and Down syndrome. Ann. Otol. Rhinol. Laryngol. 104:1995;655-661.
11. da Silva R.P., Gordon S. Phagocytosis stimulates alternative glycosylations of macrosialin (mouse CD68) a macrophage-specific endosomal protein. Biochem. J. 338:1999;687-694.
12. Davidson T.M., Murphy C. Rapid clinical evaluation of anosmia. Arch. Otolaryngol Head Neck Surg. 123:1997;591-594.
13. Davies D.C., Brooks J.W., Lewis D.A. Axonal loss from the olfactory tracts in Alzheimer's disease. Neurobiol. Aging. 14:1993;353-357.
14. Devanand D.P., Michaels-Marston K.S., Liu X., Pelton G.H., Padilla M., Marder K.et al. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am. J. Psychiatr. 157:2000;1399-1405.
15. Doty R.L., Reyes P.F., Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res. Bull. 18:1987;597-600.
16. Drew B., Leeuwenburgh C. Aging and the role of reactive nitrogen species. Ann. NY Acad. Sci. 959:2002;66-81.
17. Firestein S. How the olfactory system makes sense of scents. Nature. 413:2001;211-218.
18. Getchell M.L., Chen Y., Sparks D.L., Ding X., Getchell T.V. Immunohistochemical localization of a cytochrome P-450 isozyme in human nasal mucosa: age-related trends. Ann. Otol. Rhinol. Laryngol. 102:1993;368-374.
19. Getchell ML, Getchell TV. Differential expression of cell-specific molecules in olfactory receptor neurons of humans of different ages. In: Kurihara K, Suzuki N, Ogawa H, editors. Olfaction and Taste XI. Tokyo: Springer; 1994. p. 602-3.
20. Getchell T.V., Shah D.S., Partin J.V., Subhedar N.K., Getchell M.L. Leukemia inhibitory factor mRNA expression is upregulated in macrophages and olfactory receptor neurons after target ablation. J. Neurosci. Res. 67:2002;246-254.
21. Good P.F., Werner P., Hsu A., Olanow C.W., Perl D.P. Evidence for neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149:1996;21-28.
22. Graves A.B., Bowen J.D., Rajaram L., McCormick W.C., McCurry S.M., Schellenberg G.D.et al. Impaired olfaction as a marker for cognitive decline Interaction with apolipoprotein E ε4 status. Neurology. 53:1999;1480-1487.
23. Greenacre S.A., Ischiropoulos H. Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic. Res. 34:2001;541-581.
24. Greer CA. Structural organization of the olfactory system. In: Getchell TV, Doty RL, Bartoshuk LM, Snow Jr JB, editors. Smell and taste in health and disease. New YorK: Raven Press; 1991. p. 65-81.
25. Guzik T.J., West N.E.J., Pillai R., Taggart D.P., Channon K.M. Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension. 39:2002;1088-1094.
26. Hamilton C.A., Brosnan M.J., McIntyre M., Graham D., Dominiczak A.F. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension. 37:2001;529-534.
27. Hanazawa T., Antuni J.D., Kharitonov S.A., Barnes P.J. Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis. J. Allergy Clin. Immunol. 105:2000;58-64.
28. Harris E.D. Regulation of antioxidant enzymes. FASEB J. 6:1992;2675-2683.
29. Hensley K., Maidt M.L., Yu Z., Sang H., Markesbery W.R., Floyd R.A. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J. Neurosci. 18:1998;8126-8132.
30. Hurst J.K. Whence nitrotyrosine? J. Clin. Invest. 109:2002;1287-1289.
31. Ischiropoulos H., Zhu L., Beckman J.S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298:1992;446-451.
32. Jafek B.W. Ultrastructure of human nasal mucosa. Laryngoscope. 93:1983;1576-1599.
33. Kang B.-H., Chen S.-S., Jou L.-S., Weng P.-K., Wang H.-W. Immunolocalization of inducible nitric oxide sythase and 3-nitrotyrosine in the nasal mucosa of patients with rhinitis. Eur. Arch. Otorhinolaryngol. 257:2000;242-246.
34. Klotz L.-O. Oxidant-induced signaling: effects of peroxynitrite and singlet oxygen. Biol. Chem. 383:2002;443-456.
35. Koppenol W.H. The basic chemistry of nitrogen monoxide and peroxynitrite. Free Radic. Biol. Med. 25:1998;385-391.
36. Kulkarni A.P., Getchell T.V., Getchell M.L. Nitric oxide synthase is localized in nerves regulating perireceptor processes associated with sensory transduction in the chemosensory mucosae of rats and humans. J. Comp. Neurol. 345:1994;125-138.
37. Kulkarni-Narla A., Getchell T.V., Schmitt F.A., Getchell M.L. Manganese and copper-zinc superoxide dismutases in the human olfactory mucosa: increased immunoreactivity in Alzheimer's disease. Exp. Neurol. 140:1996;115-125.
38. Lee J.H., Goedert M., Hill W.D., Lee V.M.Y., Trojanowski J.Q. Tau proteins are abnormally expressed in olfactory epithelium of Alzheimer patients and developmentally regulated in human fetal spinal cord. Exp. Neurol. 121:1993;93-105.
39. Leopold D.A., Hummel T., Schwob J.E., Hong S.C., Knecht M., Kobal G. Anterior distribution of human olfactory epithelium. Laryngoscope. 110:2000;417-421.
40. MacMillan-Crow L.A., Cruthirds D.L. Invited review: manganese superoxide dismutase in disease. Free Radic. Res. 34:2001;325-336.
41. Mark R.J., Blanc E.M., Mattson M. Amyloid β-peptide and oxidative cellular injury in Alzheimer's disease. Mol. Neurobiol. 12:1996;211-224.
42. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-147.
43. Markesbery W.R. The role of oxidative stress in Alzheimer disease. Arch. Neurol. 56:1999;1449-1452.
44. Mattson M.P. Central role of oxyradicals in the mechanism of amyloid β-peptide cytotoxicity. Alzheimer's Dis. Rev. 2:1997;1-14.
45. McCaffrey TV. Rhinomanometry and vasoactive drugs affecting nasal patency. In: Getchell TV, Doty RL, Bartoshuk LM, Snow Jr JB, editors. Smell and Taste in Health and Disease. New York: Raven Press; 2002. p. 493-502.
46. McKhann G., Drachman D., Folstein M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
47. Mesholam R.I., Moberg P.J., Mahr R.N., Doty R.L. Olfaction in neurodegerative disease. A meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch. Neurol. 55:1998;84-90.
48. Mirra S.S., Heyman A., McKeel D., Sumi S.M.et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
49. Mozell MM, Kent PF, Scherer PW, Hornung DE, Murphy SJ. Nasal airflow. In: Getchell TV, Doty RL, Bartoshuk LM, Snow Jr JB, editors. Smell and Taste in health and disease. New York: Raven Press; 1991. p. 481-92.
50. Murphy C. Loss of olfactory function in dementing disease. Physiol. Behav. 66:1998;177-182.
51. Murphy C., Gilmore M.M., Seery C.S., Salmon D.P., Lasker B.R. Olfactory thresholds are associated with degree of dementia in Alzheimer's disease. Neurobiol. Aging. 11:1990;465-469.
52. Nakashima T., Kimmelman C.P., Snow J.B. Jr. Structure of human fetal and adult olfactory neuroepithelium. Arch. Otolaryngol. 110:1984;641-646.
53. Nordin S., Murphy C. Impaired sensory and cognitive olfactory function in questionable Alzheimer's disease. Neuropsychology. 10:1996;112-119.
54. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K.et al. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropath. Exp. Neurol. 60:2001;759-767.
55. Paik S.I., Lehman M.N., Seiden A.M., Duncan H.J., Smith D.V. Human olfactory biopsy. The influence of age and receptor distribution. Arch. Otolaryngol. Head Neck Surg. 118:1992;731-738.
56. Perlmutter L.S., Scott S.A., Barron E., Chui H.C. MHC class II-positive microglia in human brain: association with Alzheimer lesions. J. Neurosci. Res. 33:1992;549-558.
57. Perry G., Nunomura A., Hirai K., Takeda A., Aliev G., Smith M.A. Oxidative damage in Alzheimer's disease: the metabolic dimension. Int. J. Dev. Neurosci. 18:2000;417-421.
58. Rabinowitz S.S., Gordon S. Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli. J. Exp. Med. 174:1991;827-836.
59. Radi R., Cassina A., Hodara R. Nitric oxide and peroxynitrite interactions with mitochondria. Biol. Chem. 383:2002;401-409.
60. Radi R., Peluffo G., Alvarez M.N., Naviliat M., Cayota A. Unraveling peroxynitrite formation in biological systems. Free Radic. Biol. Med. 30:2001;463-488.
61. Rama Krishna N.S., Getchell T.V., Dhooper N., Awasthi Y.C., Getchell M.L. Age- and gender-related trends in the expression of glutathione S-transferases in human nasal mucosa. Ann. Otol. Rhinol. Laryngol. 104:1995;812-822.
62. Restrepo D., Teeter J.H., Schild D. Second messenger signaling in olfactory transduction. J. Neurobiol. 30:1996;37-48.
63. Rodrigues M.R., Rodriguez D., Russo M., Campa A. Macrophage activation includes high intracellular myeloperoxidase activity. Biochem. Biophys. Res. Commun. 292:2002;869-873.
64. Röhrdanz E., Schmuck G., Ohler S., Kahl R. The influence of oxidative stress on catalase and MnSOD gene transcription in astrocytes. Brain Res. 900:2001;128-136.
65. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol. Immunol. 38:2001;881-885.
66. Sato M., Fukuyama N., Sakai M., Nakazawa H. Increased nitric oxide in nasal lavage fluid and nitrotyrosine formation in nasal mucosa-indices for severe perennial nasal allergy. Clin. Exp. Allergy. 28:1998;597-605.
67. Schiffman S.S., Clark C.M., Warwick Z.S. Gustatory and olfactory dysfunction in dementia: not specific to Alzheimer's disease. Neurobiol. Aging. 11:1990;597-600.
68. Schiffman S.S., Graham B.G., Sattely-Miller E.A., Zervakis J., Welsh-Bohmer K. Taste, smell and neuropsychological performance of individuals at familial risk for Alzheimer's disease. Neurobiol. Aging. 23:2002;397-404.
69. Serby M., Mohan C., Aryan M., Williams L., Mohs R.C., Davis K.L. Olfactory identification deficits in relatives of Alzheimer's disease patients. Biol. Psychiatry. 39:1996;375-377.
70. Smith M.A., Nunomura A., Zhu X., Takeda A., Perry G. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. Antioxidants Redox Signaling. 2:2000;413-420.
71. Smith M.A., Richey Harris P.L., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17:1997;2653-2657.
72. Smith M.J., Koch G.L. Differential expression of murine macrophage surface glycoprotein antigens in intracellular membranes. J. Cell Sci. 87:1987;113-119.
73. Squier T.C. Oxidative stress and protein aggregation during biological aging. Exp. Gerontol. 36:2001;1539-1550.
74. Streit W.J., Walter S.A., Pennell N.A. Reactive microgliosis. Prog. Neurobiol. 57:1999;563-581.
75. Struble R.G., Clark H.B. Olfactory bulb lesions in Alzheimer's disease. Neurobiol. Aging. 13:1992;469-473.
76. Su J.H., Deng G., Cotman C.W. Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain. Brain Res. 774:1997;193-199.
77. Suzuki Y., Schafer J., Farbman A.I. Phagocytic cells in the rat olfactory epithelium after bulbectomy. Exp. Neurol. 136:1995;225-233.
78. Tabaton M., Cammarata S., Mancardi G.L., Cordone G., Perry G., Loeb C. Abnormal tau-reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease. Neurology. 41:1991;391-394.
79. Takeuchi A., Miyaishi O., Kiuchi K., Usobe K. Cu/Zn-and Mn-superoxide dismutases are specifically up-regulated in neurons after focal brain injury. J. Neurobiol. 45:2000;39-46.
80. Talamo B.R., Rudel R., Kosik K.S., Lee V.M.Y., Neff S., Adelman L.et al. Pathological changes in olfactory neurons in patients with Alzheimer's disease. Nature. 337:1989;736-739.
81. Tohgi H., Abe T., Yamazaki K., Murata T., Ishizaki E., Isobe C. Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Neurosci. Lett. 269:1999;52-54.
82. Trojanowski J.Q., Newman P.D., Hill W.D., Lee V.M.Y. Human olfactory epithelium in normal aging, Alzheimer's disease, and other neurodegenerative disorders. J. Comp. Neurol. 310:1991;365-376.
83. van der Loo B., Labugger R., Skepper J.N., Bachschmid M., Kilo J., Powell J.M.et al. Enhanced peroxynitrite formation is associated with vascular aging. J. Exp. Med. 192:2000;1731-1734.
84. Weiffenbach JM. Chemical senses in aging. In: Getchell TV, Doty RL, Bartoshuk LM, Snow Jr JB, editors. Smell and taste in health and disease. New York: Raven Press; 1991. p. 369-78.
85. Williamson K.S., Gabbita S.P., Mou S., West M., Pye Q.N., Markesbery W.R.et al. The nitration product 5-nitro-γ-tocopherol is increased in the Alzheimer brain. Nitric oxide. 6:2002;221-227.
86. Wink D.A., Mitchell J.B. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 25:1998;434-456.
87. 1-42- and lipopolysaccharide-activated microglia. J. Neurosci. 22:2002;3484-3492.
88. Yamagishi M., Getchell M.L., Takami S., Getchell T.V. Increased density of olfactory receptor neurons immunoreactive for apolipoprotein E in patients with Alzheimer's disease. Ann. Otol. Rhinol. Laryngol. 107:1998;421-426.